1. Home
  2. CALC vs SOTK Comparison

CALC vs SOTK Comparison

Compare CALC & SOTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CALC
  • SOTK
  • Stock Information
  • Founded
  • CALC 2011
  • SOTK 1975
  • Country
  • CALC United States
  • SOTK United States
  • Employees
  • CALC 15
  • SOTK N/A
  • Industry
  • CALC Biotechnology: Pharmaceutical Preparations
  • SOTK Industrial Machinery/Components
  • Sector
  • CALC Health Care
  • SOTK Technology
  • Exchange
  • CALC Nasdaq
  • SOTK Nasdaq
  • Market Cap
  • CALC 45.4M
  • SOTK 52.1M
  • IPO Year
  • CALC N/A
  • SOTK 1987
  • Fundamental
  • Price
  • CALC $3.23
  • SOTK $4.22
  • Analyst Decision
  • CALC Strong Buy
  • SOTK Hold
  • Analyst Count
  • CALC 2
  • SOTK 1
  • Target Price
  • CALC $14.50
  • SOTK N/A
  • AVG Volume (30 Days)
  • CALC 52.6K
  • SOTK 21.5K
  • Earning Date
  • CALC 11-12-2025
  • SOTK 10-14-2025
  • Dividend Yield
  • CALC N/A
  • SOTK N/A
  • EPS Growth
  • CALC N/A
  • SOTK 6.63
  • EPS
  • CALC N/A
  • SOTK 0.10
  • Revenue
  • CALC N/A
  • SOTK $20,607,030.00
  • Revenue This Year
  • CALC N/A
  • SOTK $5.04
  • Revenue Next Year
  • CALC N/A
  • SOTK $4.31
  • P/E Ratio
  • CALC N/A
  • SOTK $43.55
  • Revenue Growth
  • CALC N/A
  • SOTK N/A
  • 52 Week Low
  • CALC $1.42
  • SOTK $3.23
  • 52 Week High
  • CALC $5.65
  • SOTK $6.05
  • Technical
  • Relative Strength Index (RSI)
  • CALC 52.57
  • SOTK 53.66
  • Support Level
  • CALC $3.13
  • SOTK $4.05
  • Resistance Level
  • CALC $3.33
  • SOTK $4.67
  • Average True Range (ATR)
  • CALC 0.20
  • SOTK 0.25
  • MACD
  • CALC -0.00
  • SOTK -0.06
  • Stochastic Oscillator
  • CALC 38.24
  • SOTK 26.16

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

Share on Social Networks: